Tryptamine Therapeutics Announces Successful Fundraising

Therapeutic tryptamine (AU:TYP) posted an update.

Tryptamine Therapeutics Limited successfully completed multiple offerings, raising a total of $6.5 million and issuing over 1.5 billion shares and options following the acquisition of Tryp Therapeutics Inc. This strategic move significantly expanded the company’s capital structure, now comprising more than 1.1 billion shares and 445 million options. Bolstered by this financial momentum, Tryptamine’s pro forma financials demonstrate a strong cash position, providing a promising path for future growth.

For more news on AU:TYP stock, check out TipRanks. Inventory Analysis page.